查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1777531

全球骶髂关节固定市场

Sacroiliac Joint Fusion
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 374 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球骶髂关节融合市场将达到 25 亿美元

全球骶髂关节融合市场规模预计在2024年达到8.383亿美元，预计在2024-2030年的分析期内将以20.4%的复合年增长率增长，到2030年将达到25亿美元。退化性骶髂关节炎是本报告分析的细分市场之一，预计其复合年增长率将达到22.3%，到分析期结束时规模将达到17亿美元。骶骨骨折节段的复合年增长率预计在分析期内将达到16.5%。

美国市场规模估计为 2.284 亿美元，中国市场预计复合年增长率为 26.9%

美国骶髂关节融合市场规模预计在2024年达到2.284亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到5.894亿美元，在2024-2030年的分析期内，复合年增长率为26.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为15.0%和18.5%。在欧洲，预计德国市场的复合年增长率约为16.3%。

全球骶髂关节融合市场—主要趋势与驱动因素摘要

骶髂关节融合手术为何在整形外科治疗中受到关注？

骶髂关节 (SI) 功能障碍是下腰痛的重要原因，影响全球数百万人。随着人们对 SI 关节相关疼痛的认识不断提高，骶髂关节融合手术已成为一种广泛采用的治疗方法，适用于对物理治疗、疼痛管理、注射等保守治疗无效的患者。此手术使用植入或骨移植来稳定 SI 关节，减轻疼痛并改善活动能力。退化性关节病变、创伤相关损伤以及肥胖和久坐等生活方式因素的日益流行，正在推动 SI 关节融合手术的需求。此外，微创手术技术的进步正在提高手术安全性、缩短復原时间并改善患者预后。全球人口老化和医疗支出的不断增长，正在推动骶髂关节融合手术市场的强劲成长。

哪些技术创新正在改变骶髂关节融合手术？

医疗技术的进步显着提高了骶髂关节融合手术的准确性和有效性。微创手术 (MIS) 技术的发展缩短了手术时间、减少了术后疼痛并缩短了恢復期。影像引导导航系统和机器人辅助手术提高了手术精度并降低了併发症风险。此外，由钛和 3D 列印多孔材料製成的生物相容性植入透过促进骨骼生长和稳定性提高了融合手术的成功率。移植骨替代物和生长因子等生物製药的使用也改善了融合效果。这些技术创新使骶髂关节融合成为对患者和医疗保健提供者更具吸引力的选择。

哪些病患小组和医疗保健领域正在推动对骶髂关节融合的需求？

骶髂关节融合术的主要病患小组包括患有慢性下腰痛、关节炎、创伤相关损伤以及产后骨盆不稳定的患者。易患退化性关节疾病的老年患者占了相当大的市场。此外，运动员和从事体力劳动的族群罹患荐髂关节功能障碍的风险更高，增加了对外科手术的需求。由于报销政策的改善和经济高效的门诊手术选择，越来越多的医院和门诊手术中心 (ASC) 开始采用骶髂关节融合术。随着越来越多的整形外科专家和疼痛管理诊所将骶髂关节融合术纳入其诊疗实践，预计市场将进一步扩大。

哪些因素推动了骶髂关节融合手术市场的成长？

骶髂关节融合市场的成长动力源于人们对骶髂关节功能障碍认识的不断提高、微创手术的进步以及易患退化性关节疾病的老龄化人口。机器人辅助手术和影像导航系统的日益普及，正在改善手术效果，进一步推动市场应用。优惠的报销政策和疼痛管理解决方案医疗支出的不断增长也促进了市场的成长。此外，久坐的生活方式和肥胖率的上升也导致下腰痛的发病率上升，从而导致寻求手术治疗的患者数量增加。随着研究不断完善治疗方法，预计骶髂关节融合市场将持续扩张。

部分

适应症（退化性骶髂关节疾病、荐骨骨折、创伤）；治疗类型（手术、注射、射频消融）；最终使用者（医院、门诊手术中心、其他）

受访公司范例

  • Alphatec Spine, Inc.
  • Aurora Spine Corporation
  • Camber Spine Technologies, LLC
  • CoreLink Surgical
  • DePuy Synthes（Johnson & Johnson）
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corp.
  • Life Spine, Inc.
  • Medacta International
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • PainTEQ
  • RTI Surgical Holdings, Inc.
  • SI-BONE, Inc.
  • SIGNUS Medizintechnik GmbH
  • VGI Medical
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Zyga Technology, Inc.

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP32859

Global Sacroiliac Joint Fusion Market to Reach US$2.5 Billion by 2030

The global market for Sacroiliac Joint Fusion estimated at US$838.3 Million in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 20.4% over the analysis period 2024-2030. Degenerative Sacroiliitis, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Sacral Disruption segment is estimated at 16.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$228.4 Million While China is Forecast to Grow at 26.9% CAGR

The Sacroiliac Joint Fusion market in the U.S. is estimated at US$228.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$589.4 Million by the year 2030 trailing a CAGR of 26.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.0% and 18.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.

Global Sacroiliac Joint Fusion Market - Key Trends & Drivers Summarized

Why Is Sacroiliac Joint Fusion Gaining Prominence In Orthopedic Treatments?

Sacroiliac (SI) joint dysfunction is a significant cause of lower back pain, affecting millions of people worldwide. As awareness of SI joint-related pain grows, sacroiliac joint fusion is becoming a widely adopted treatment option for patients who do not respond to conservative therapies such as physical therapy, pain management, and injections. The procedure involves stabilizing the SI joint using implants or bone grafts to reduce pain and improve mobility. The increasing prevalence of degenerative joint diseases, trauma-related injuries, and lifestyle factors such as obesity and prolonged sitting are fueling demand for SI joint fusion surgeries. Additionally, advancements in minimally invasive surgical techniques are making the procedure safer, reducing recovery times, and improving patient outcomes. With an aging global population and rising healthcare expenditure, the sacroiliac joint fusion market is experiencing strong growth.

What Technological Innovations Are Transforming Sacroiliac Joint Fusion Procedures?

Advancements in medical technology are significantly enhancing the precision and effectiveness of SI joint fusion procedures. The development of minimally invasive surgical (MIS) techniques has reduced operative times, post-surgical pain, and recovery periods. Image-guided navigation systems and robotic-assisted surgery are improving surgical accuracy, reducing the risk of complications. Additionally, biocompatible implants made from titanium and 3D-printed porous materials are increasing the success rates of fusion procedures by promoting bone growth and stability. The use of biologics, such as bone graft substitutes and growth factors, is also enhancing fusion outcomes. These innovations are making sacroiliac joint fusion a more attractive option for both patients and healthcare providers.

Which Patient Groups And Healthcare Sectors Are Driving The Demand For SI Joint Fusion?

The primary patient groups benefiting from sacroiliac joint fusion include individuals suffering from chronic lower back pain, arthritis, trauma-related injuries, and post-pregnancy pelvic instability. Geriatric patients, who are more prone to degenerative joint conditions, represent a significant portion of the market. Additionally, athletes and individuals engaged in physically demanding jobs are at higher risk of SI joint dysfunction, increasing demand for surgical interventions. The hospital and ambulatory surgery center (ASC) sectors are experiencing heightened adoption of SI joint fusion procedures due to improved reimbursement policies and cost-effective outpatient surgical options. As more orthopedic specialists and pain management clinics incorporate SI joint fusion into their treatment offerings, the market is expected to expand further.

What Factors Are Fueling The Growth Of The Sacroiliac Joint Fusion Market?

The growth in the sacroiliac joint fusion market is driven by increasing awareness of SI joint dysfunction, advancements in minimally invasive surgery, and a rising aging population prone to degenerative joint diseases. The growing adoption of robotic-assisted procedures and image-guided navigation systems is improving surgical outcomes, further driving market adoption. Favorable reimbursement policies and increased healthcare expenditure on pain management solutions are also contributing to market growth. Additionally, the rising prevalence of sedentary lifestyles and obesity is increasing the incidence of lower back pain, prompting more patients to seek surgical solutions. As research continues to refine treatment approaches, the sacroiliac joint fusion market is poised for sustained expansion.

SCOPE OF STUDY:

The report analyzes the Sacroiliac Joint Fusion market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Degenerative Sacroiliitis, Sacral Disruption, Trauma); Treatment Type (Surgery, Injections, RF Ablation); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alphatec Spine, Inc.
  • Aurora Spine Corporation
  • Camber Spine Technologies, LLC
  • CoreLink Surgical
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corp.
  • Life Spine, Inc.
  • Medacta International
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • PainTEQ
  • RTI Surgical Holdings, Inc.
  • SI-BONE, Inc.
  • SIGNUS Medizintechnik GmbH
  • VGI Medical
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Zyga Technology, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sacroiliac Joint Fusion - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Lower Back Pain and Sacroiliac Joint Dysfunction Drives Demand for Sacroiliac Joint Fusion Procedures
    • Surge in Aging Populations and Degenerative Spine Disorders Expands Market Opportunity for Sacroiliac Joint Fusion Solutions
    • Rising Awareness and Acceptance of Minimally Invasive Surgical Techniques Propels Growth in Sacroiliac Joint Fusion Adoption
    • Technological Advancements in Sacroiliac Joint Fusion Implants and Devices Strengthen the Business Case for Surgery
    • Growing Preference for Outpatient and Same-Day Discharge Procedures Accelerates Adoption of Sacroiliac Joint Fusion Solutions
    • Increasing Investment in Spine Surgery Innovation and Research Expands Addressable Market for Sacroiliac Joint Fusion
    • Surge in Healthcare Spending and Investment in Surgical Infrastructure Drives Demand for Advanced Sacroiliac Joint Fusion Technologies
    • Rising Focus on Reducing Surgical Recovery Times and Enhancing Patient Outcomes Strengthens the Case for Sacroiliac Joint Fusion
    • Expansion of Surgical Options for Chronic Back Pain and Spinal Disorders Creates New Market Opportunities for Sacroiliac Joint Fusion
    • Increasing Utilization of Robotic-Assisted Surgery for Spine and Orthopedic Procedures Spurs Demand for Sacroiliac Joint Fusion Solutions
    • Regulatory Support and Clearer Approval Pathways for Sacroiliac Joint Fusion Devices Accelerate Product Adoption
    • The Shift Toward Personalized and Targeted Spine Surgery Solutions Drives Innovation in Sacroiliac Joint Fusion Technologies
    • Growing Popularity of Hybrid and Combination Procedures for Spinal Disorders Expands Market Demand for Sacroiliac Joint Fusion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sacroiliac Joint Fusion Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Sacroiliitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Sacroiliitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Sacroiliitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sacral Disruption by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION